Brookdale Senior Living $125 million tangible equity units offering
The offering comprised 2.5 million units
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Ormat Technologies $338 million secondary offering
The stock is listed on the NYSE and Tel Aviv Stock Exchange
Privia Health $135 million secondary offering
We advised Privia on its debut shelf takedown offering
Tenaya Therapeutics $75 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Natera $400 million follow-on offering
The shares are listed on Nasdaq
Alight $178 million debut secondary offering
The stock is listed on the NYSE
Kinsale Capital Group follow-on offering
The stock is listed on the NYSE
Roivant Sciences $150 million equity offering
We advised the company on its debut SEC-registered primary and secondary offering
Akoya Biosciences $50 million at-the-market program
The common stock is listed on the Nasdaq Global Select Market
Lucid $600 million at-the-market offering and $915 million additional investment
The common stock is listed on Nasdaq